With Round 1 underway, CDAF is pleased to announce that the RFP for Round 2 of the Relink grant is now open! Is your organization working to #relink diagnosed but untreated #HCV+ & #HBV+ people in the US to care?
Visit https://t.co/GEV7fhjYdB for more information.
Did you know that viral #hepatitis is a leading cause of #livercancer globally?🤔
New research by @CDAFound finds that #hepatitis B and C infected individuals “have a similar or significantly higher risk of developing cancer than someone who actively smokes one pack of cigarettes per day.”
Our recent survey also shows that nearly half (42%) of people globally are unaware that one of the leading causes of liver cancer is viral hepatitis.
This #WorldHepatitisDay, we must continue to raise awareness about the dangers of this silent killer, hepatitis, to save lives!
Learn more - https://t.co/yaqGWfMAqU
@caryjameslondon@Homie_Razavi@DanjumaAdda
#HepCantWait #NotWaiting #OneLifeOneLiver
CDA Foundation is honored to be selected for Gilead's Relink grant. This grant will be distributed to organizations in the US to link HCV & HBV diagnosed but untreated individuals back into care.
@HepBFoundation@AASLDtweets#WorldHepatitisDay#HCV https://t.co/X8RtEAF85p
#SaudiArabia is now on track to eliminate #HCV by 2030. Since 2014, 22K have been treated. In 2021 alone, >150K people were screened in primary healthcare & 340K people through premarital screening.
Congratulations for being one of 12 countries on track.
@Hep_Alliance#NoHep
Impressed by collaborators in #Kazakhstan. In <1.5 months, screened >7,000 for #HBV & #HCV, tested VL & linked pts to care. MoH approved GPs to treat pts. Our pilot will end in 2 months & will be rolled out nationally.
@hepatitisfund@Hep_Alliance@HepBFoundation@swang8
A collaborative study in #Egypt showed the elimination of #HCV was highly cost effective by 2021 & cost saving by 2029. Egypt will save $35M in direct costs and $4.7B in indirect costs by 2030.
In memory of Dr. Ezzat.
#NoHep@hepatitisfund@swang8
https://t.co/FoaADse4Gs
@swang8@WHO@AASLDtweets@EASLnews@APASLnews@Hep_Alliance @EndHep2030 The guidelines do allow for qualitative PCR which cost less and are easier to run.
In discussions with local experts, there is also an exemption for rural areas where access to PCR is limited. In those setting, HBsAg+ is sufficient to start treatment. 🙌🏻
Great graphic & story highlighting that vaccination key to elimination of #hepatitisB- even as we are on the road to finding #HepB cure.
But we desperately need @gavi to follow through w their commitment to cover #HBV birth dose vaccine in many of their countries! 👶🏽
The #WorldHepatitisSummit 2022 statement is published! This is from the >800 delegates of the #WHS22.
It's a call to action for Hepatitis Elimination by 2030.
If everyone does their part, we can make it a reality.
#HepCantWait
https://t.co/RwWRWKhTVq
Don't forget to register!
This webinar on August 17 @ 8:00am PT with @Homie_Razavi will focus on the efforts of one organization to implement decision support at the national and international levels to support viral hepatitis elimination.
Register @ https://t.co/KdYEPPwQ27